Prof. Dr. Alexander Kleger

Weitere Beteiligungen

• Do, 15.02.

  16:45 – 16:50 3 Min. 2 Min.

  • ePoster presentation
  • P21

  A comprehensive multiomics approach unravels druggable tumor – stroma interactions in ATM-deficient pancreatic cancer

   Late breaking abstract
• Do, 15.02.

  16:50 – 16:55 3 Min. 2 Min.

  • ePoster presentation
  • P22

  DKK3 in pancreatic cancer – elucidating the roles of a double-edged sword

   Late breaking abstract
• Fr, 16.02.

  11:27 – 11:39 10 Min. 2 Min.

  • Oral presentation
  • O26

  Deciphering collective oncogenic KRAS and GNAS signaling in an organoid model for cystic pancreatic neoplasia

   Cystic lesions of the pancreas
• Fr, 16.02.

  15:00 – 15:05 3 Min. 2 Min.

  • ePoster presentation
  • P43

  The EZH2 epigenetic factor coordinates oncogenic properties in ATM-deficient pancreatic cancer

   Late breaking abstract
• Sa, 17.02.

  09:20 – 09:30 8 Min. 2 Min.

  • Oral presentation
  • O49

  Modelling Johanson-Blizzard-Syndrome in a dish – molecular insights into UBR1 deficiency using pluripotent stem cell-derived ancreatic organoids

   Tumour microenvironment, epigenetics and stem cells
• Sa, 17.02.

  09:50 – 10:00 8 Min. 2 Min.

  • Oral presentation
  • O52

  PROTOCOL trial – PROTon pump inhibitors and stent OCclusion rate Of Lumen apposing metal stents

   Acute/chronic pancreatitis
• Sa, 17.02.

  10:45 – 10:50 3 Min. 2 Min.

  • ePoster presentation
  • P64

  Pancreatic cancer patient-derived organoids, preclinical tools for therapeutic profiling, patient response prediction, and tumor evolution

   Late breaking abstract